SCHEMBL509640

SCHEMBL509640

CCO[Al](OCC)OCC.[NaH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL108892 0.96
SCHEMBL5729396 0.92
SCHEMBL384218 0.92
SCHEMBL15063009 0.92
Hydrochloric Acid SCHEMBL8853911 0.88
Lithium Ion SCHEMBL384217 0.88
SCHEMBL509639 0.88
SCHEMBL15016076 0.88
SCHEMBL11270758 0.85
SCHEMBL8736018 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3466934-B1 SULFONAMIDE COMPOUNDS OR SALT THEREOF AS RIBONUCLEOTIDE REDUCTASE INHIBITORS FOR TREATING CANCER TAIHO PHARMACEUTICAL CO LTD (JP) 2024-03-27 EP disclosed
CN-115038753-B Composition, curable composition, cured product, and storage method 株式会社钟化 2024-03-19 CN disclosed
WO-2023048155-A1 ONE-PACK TYPE CURABLE COMPOSITION AND CURED PRODUCT 株式会社カネカ 2023-03-30 WO disclosed
CN-115038753-A Composition, curable composition, cured product and storage method 株式会社钟化 2022-09-09 CN disclosed
CN-109563057-B Sulfonamide compound or salt thereof 大鹏药品工业株式会社 2022-06-24 CN disclosed
EP-3673908-B1 ANTI-TUMOR EFFECT POTENTIATOR TAIHO PHARMACEUTICAL CO LTD (JP) 2022-01-12 EP disclosed
US-10889555-B2 Sulfonamide compound or salt thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-01-12 US disclosed
US-20200405697-A1 Antitumor Agent TAIHO PHARMACEUTICAL CO., LTD. (JP) 2020-12-31 US disclosed
US-20200399235-A1 Sulfonamide Compound or Salt Thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2020-12-24 US disclosed
EP-3718545-A1 ANTITUMOR AGENT Taiho Pharmaceutical Co., Ltd. (JP) 2020-10-07 EP disclosed
EP-0013592-B1 N,N-DISUBSTITUTED-AMINOMETHYL-PHENYLETHANOLAMINES AND PHARMACEUTICAL FORMULATIONS THEREOF PFIZER INC. (US) 1982-12-15 EP disclosed
EP-0022229-B1 SUBSTITUTED PHENOL ETHERS, THEIR PREPARATION, INTERMEDIATES THEREFOR, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THE PREPARATION THEREOF THE WELLCOME FOUNDATION LIMITED (GB) 1982-12-08 EP disclosed
EP-0063950-A1 Aminocyclitols and their production Takeda Chemical Industries, Ltd. (JP) 1982-11-03 EP disclosed
EP-0054924-A2 Pharmaceutical compounds, their preparation and use THE WELLCOME FOUNDATION LIMITED (GB) 1982-06-30 EP disclosed
EP-0022229-A1 Substituted phenol ethers, their preparation, intermediates therefor, pharmaceutical compositions containing them and the preparation thereof THE WELLCOME FOUNDATION LIMITED (GB) 1981-01-14 EP disclosed
US-4229466-A TREATING NEPHRITIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1980-10-21 US disclosed
EP-0013592-A1 N,N-disubstituted-aminomethyl-phenylethanolamines and pharmaceutical formulations thereof PFIZER INC. (US) 1980-07-23 EP disclosed
US-4211794-A ANTIVIRAL INTERFERON PRODUCTION PFIZER INC. (US) 1980-07-08 US disclosed
US-3981887-A Sulfoxides and sulfones MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) 1976-09-21 US disclosed
US-3941775-A 6-Aza-3H-1,4-benzodiazepines DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) 1976-03-02 US disclosed